These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35117172)

  • 21. Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis.
    Liu J; Meng H; Li S; Shen Y; Wang H; Shan W; Qiu J; Zhang J; Cheng W
    Front Genet; 2019; 10():1031. PubMed ID: 31708970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic analysis of the role of solute carrier-glutamine transporters in breast cancer.
    Zhao X; Jin L; Liu Y; Liu Z; Liu Q
    Ann Transl Med; 2022 Jul; 10(14):777. PubMed ID: 35965834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
    Han B; Zhen F; Zheng XS; Hu J; Chen XS
    BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERĪ±-Positive Breast Cancer.
    Alhammad R
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.
    Gao B; Liu X; Li Z; Zhao L; Pan Y
    Front Oncol; 2020; 10():600514. PubMed ID: 33665162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
    Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
    Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaphase-promoting complex/cyclosome-Cdc-20 promotes Zwint-1 degradation.
    He Y; Li R; Gu L; Deng H; Zhao Y; Guo Y; Yu S; Wang G
    Cell Biochem Funct; 2020 Jun; 38(4):451-459. PubMed ID: 31945194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and Prognostic Characteristics of m
    Zhang B; Gu Y; Jiang G
    Front Genet; 2020; 11():604597. PubMed ID: 33362863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
    Huo Q; Li Z; Cheng L; Yang F; Xie N
    Front Oncol; 2020; 10():621. PubMed ID: 32528869
    [No Abstract]   [Full Text] [Related]  

  • 32. Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.
    Wang J; Ye C; Lu D; Chen Y; Jia Y; Ying X; Xiong H; Zhao W; Zhou J; Wang L
    Oncotarget; 2017 Oct; 8(53):91379-91390. PubMed ID: 29207651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of KIF23 expression in gastric cancer.
    Liang WT; Liu XF; Huang HB; Gao ZM; Li K
    World J Gastrointest Oncol; 2020 Oct; 12(10):1104-1118. PubMed ID: 33133380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.
    Zeng K; Ju G; Wang H; Huang J
    Transl Cancer Res; 2020 Apr; 9(4):2363-2377. PubMed ID: 35117597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
    Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
    Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive analysis of the diagnostic and prognostic value associated with the
    Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T
    Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
    Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
    World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 40. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
    Li J; Su T; Yang L; Zhang C; He Y
    Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.